A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry

Christian Schumann; Franz Heigl; Imanuel J. Rohrbach; Ahmed Sheriff; Lutz Wagner; Florian Wagner; Jan Torzewski

doi:10.12659/AJCR.935263

10 January 2022 : Case report Germany

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry

Unusual clinical course, Unusual or unexpected effect of treatment

Christian Schumann^1ABCDEFG, Franz Heigl^2BDE, Imanuel J. Rohrbach^3BCDEF, Ahmed Sheriff^45ABDE, Lutz Wagner^6BCDE, Florian Wagner^6CDEF, Jan Torzewski^3ABCDEFG*

DOI: 10.12659/AJCR.935263

Am J Case Rep 2022; 23:e935263

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

View HTML version

Figure 4. (A–F) Non-respiratory parameters. Figure shows laboratory parameters indicating organ function. Whereas all patients showed LDH elevation, none of them developed acute renal (creatinine) or hepatic (bilirubin) failure, and none of them developed blood coagulation (INR) derailment. Blue shadows: reference ranges. Dashed lines: patient discharge.

Back to the Article

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry

Your Privacy